Health care automation startup Olive AI plans to sell one of the two remaining business lines advertised on its website, per current and former employees and an internal company memo seen by Axios.
Why it matters: Olive has been shrinking since facing questions about its software's efficacy, multiple executive departures, a previous asset sale, and two major layoffs.
